InvestorsHub Logo
icon url

hssbwwmp

01/02/23 6:03 PM

#112468 RE: posterschild #112467

Interesting rumor, but I'm not sure we have heard the last of the PLpro anti-Coronavirus mice trials from the University of Arizona or the upcoming K1.1-LNP xenograft mice in vivo cancer trials in March 2023.

Nonetheless, the RS has clearly failed. Had the PPS stayed above $4 (or even $2) in 2022 I might have thought otherwise. If it gets back to $2-4+ in 2023 then I'll have different thoughts on this!
icon url

bbartgen

01/03/23 11:22 AM

#112471 RE: posterschild #112467

Working with an insider to what? If hed just focus on running a solid business he wouldn’t have to worry about an opinion board. That is exactly why this company sucks. Worried about shit that isn’t even a problem.
icon url

GMJDubbs

01/03/23 6:25 PM

#112472 RE: posterschild #112467

No he hasn’t …. Stupidest post of THIS year so far….